CDKN2B-AS1 and non-small cell lung carcinoma: In 2016, Lu et al [18] elaborated that there was a positive correlation between the expression levels of CDKN2B antisense RNA 1 (ANRIL) and c-Myc, and decreased ANRIL significantly inhibited NSCLC cell proliferation.